ChartMill assigns a Buy % Consensus number of 78% to LUMO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-10-24 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-10-23 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-24 | EF Hutton | Initiate | Buy |
| 2024-08-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-06 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-08 | Jefferies | Downgrade | Buy -> Hold |
| 2022-11-15 | Jefferies | Downgrade | Buy -> Hold |
| 2022-07-20 | Oppenheimer | Initiate | Outperform |
| 2021-11-04 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-11 | Stifel | Upgrade | Hold -> Buy |
10 analysts have analysed LUMO and the average price target is 9.88 USD. This implies a price increase of 127.68% is expected in the next year compared to the current price of 4.34.
The consensus rating for LUMOS PHARMA INC (LUMO) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.